| 000 | 01044 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513044058.0 | ||
| 264 | 0 | _c19950202 | |
| 008 | 199502s 0 0 eng d | ||
| 022 | _a1062-8401 | ||
| 024 | 7 |
_a10.1089/cbr.1993.8.115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChasen, M R | |
| 245 | 0 | 0 |
_aLeukemia after chemotherapy for cancer. _h[electronic resource] |
| 260 |
_bCancer biotherapy _c1993 |
||
| 300 |
_a115-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia _xchemically induced |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xchemically induced |
| 700 | 1 | _aFalkson, G | |
| 773 | 0 |
_tCancer biotherapy _gvol. 8 _gno. 2 _gp. 115-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/cbr.1993.8.115 _zAvailable from publisher's website |
| 999 |
_c7803709 _d7803709 |
||